Recent Publications
In a healthcare marketplace increasingly driven by consumerism, it is critically important for patients to have access to data sufficient to enable them to be more informed, engaged and empowered to make decisions about their own care. Indeed, enhanced consumer engagement helps healthcare payors and healthcare providers improve patient acquisition and retention, strengthens brand value, lowers administrative costs, and leads to competitive advantages. Most importantly, greater consumer engagement can improve the health outcomes and quality of life of patients.
Faced with the growing challenge of finding attractive investment opportunities, private-equity firms have increasingly turned to the healthcare industry to bolster returns for themselves and their investors. In 2017, according to one estimate, the disclosed value of healthcare-related private equity deals reached roughly $42.6 billion. Despite fundamental uncertainty in the healthcare market – much of it driven by the political climate – healthcare spending in the United States has grown faster than GDP for decades, and $3.5 trillion was spent on healthcare in 2017 alone.
As you may be aware, Medical Malpractice Insurance, New York (“MLMIC”) is currently in the process of being acquired by National Indemnity Company (“NICO”), a Berkshire Hathaway subsidiary. Currently, MLMIC is a mutual insurance company, meaning it is owned by its policyholders/insured physicians. Once the sale to NICO is complete, however, the company will be transitioned to a stock insurance company owned by NICO’s shareholders.
READ MORE